2 hrs ago
NHS Rules Face Challenge From Changing Healthcare AI
AI is becoming more common in NHS healthcare.
The medical regulator says current rules were mostly designed for devices that do not change after approval.
Some AI systems can learn from new data and behave differently later.
The regulator has suggested 44 ways to improve oversight.
These include checking systems continuously and removing approval if they stop working well.
Patients might also be told when AI is involved in their care.
AI scribes can save doctors time by creating consultation notes, but they can make mistakes.
Some patients may share less personal information if they know AI is listening.
Doctors, patients, and regulators must balance AI’s possible benefits with its risks.
The Medicines and Healthcare products Regulatory Agency has published 44 recommendations for regulating healthcare AI.
The proposals include continuous monitoring, possible removal of approval, and penalties for developers whose products fail standards.
Patients could gain rights to know when AI is used in their care and how it operates.
AI systems can change after approval as they learn from new data, unlike many traditional medical devices.
AI scribes are reportedly used by around 40% of UK GPs, but studies and clinicians have raised concerns about privacy, errors, and trust.
- Who
- The Medicines and Healthcare products Regulatory Agency, an independent commission, patients, clinicians, and healthcare AI developers are involved.
- What
- The MHRA has proposed 44 recommendations to update regulation of AI products used in healthcare.
- Where
- The proposals concern healthcare in Britain, including the NHS and UK general practices.
- When
- The recommendations were published as AI is increasingly being used in NHS healthcare; the articles do not give a publication date.
- Why
- Existing medical-device rules were designed for products that generally remain stable after approval, while AI can learn, adapt, or drift after deployment.
Healthcare AI Opportunity
Healthcare AI Risks
Efficiency and medical progress
Healthcare AI Opportunity
Supporters say AI could save doctors time, improve healthcare, and become a major advance comparable to antibiotics or MRI.
Healthcare AI Risks
Critics point to incorrect advice, biased training data, and confident but wrong conclusions as potential harms.
Patient participation
Healthcare AI Opportunity
Patients could benefit from AI-assisted consultations and greater transparency through a right to know when AI is being used.
Healthcare AI Risks
Some patients may refuse AI involvement or disclose less sensitive information when they know a system is processing their consultation.
Responsibility and oversight
Healthcare AI Opportunity
Continuous monitoring, supervised trials, and human checking could help keep AI products safe as they change.
Healthcare AI Risks
AI systems can evolve after approval, raising questions about whether doctors can realistically remain responsible for every clinical decision involving AI.
Key facts
- Regulator
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Recommendations
- 44 proposed recommendations
- Consultation
- More than 12,000 people, including patients and clinicians, were consulted
- Potential patient right
- To know when AI is involved in their care and access information about the products used
- Proposed oversight
- Continuous monitoring, possible removal of approval, and penalties for developers
- Current NHS use
- AI-powered medical scribes are reportedly used by around 40% of UK GPs
- Proposed testing measure
- An AI “L plate” system for supervised trials by healthcare professionals
Quotes
Henrietta Hughes
GP and contributor to the MHRA report
“Unlike most of the medical products we're used to regulating, these products continue to change after the point of authorization”
easterneye.biz
“That should happen in a way that they can maintain their trust and their confidence in what’s happening.”
easterneye.biz
Sources
Related news
India’s Pharma Industry Embraces AI Amid Regulatory Concerns
AI in Healthcare May Weaken Trust in Doctors and Therapists
What India Can Learn From the EU’s Adaptive AI Reset
Indian Healthcare Providers Move AI Pilots Into Practice
Zuckerberg Challenges Proposed FINRA-Style AI Watchdog
RBI Deputy Governor Urges Banks to Stress-Test AI Systems
Home Urine Test Shows Promise for Detecting Bladder Cancer
New At-Home Urine Test Detects 92% of Bladder Cancers
Bank of England Warns AI Boom Could Trigger Market Shock
India's Rising Caesarean Rates Raise Calls for Dignified Childbirth
